REFERENCES
- Jemilohun AC, Adewoye OG. liver cirrhosis from autoimmune hepatitis in
a Nigerian woman: a case report. Ann Ibd. Pg. Med. 2017; 15
(2): 133-136.
- Chazouillère O. A case of auto-immune hepatitis. GastroenterolClin Biol 2009; 33: 36-43.
- Jemilohun AC, Ola TS. Autoimmune Liver Diseases in Native Black
Africans: Extremely Rare or Inadequately Investigated Diseases?JAMMR. 2017; 24(7): 1-14.
- European Association for the Study of the Liver. EASL Clinical
Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015; 63:
971-1004.
- Gleeson D, Heneghan MA. British Society of Gastroenterology (BSG)
guidelines for management of autoimmune hepatitis. Gut .
2011 :1-19.
- Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of
Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance
and Guidelines from the American Association for the Study of Liver
Diseases. Hepatology . 2020; 0(0): 1-52.
- Corpechot C, Chazouillères O. autoimmune hepatitis: Diagnostic and
therapeutic up-to-date. Rev Med int. 2010; 13: 606-14.
- Lemoinne S, Wendum D, Corpechot C, Chazouillères O. Hépatites
auto-immunes : aspects diagnostiques et thérapeutiques. Hépato
Gastro. 2016 ; 23 : 637-52. doi : 10.1684/hpg.2016.1323.
- Gournay J. L’hepatite auto-immune. Hépato Gastro. 2017; 24:
830-845. doi : 10.1684/hpg.2017.1521.
- Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges.Gastroenterology. 2001; 120: 1502-17.
- Manns MP, Bahr MJ, Woynarowski M, et al. Budesonide 3 mg tid is
superior to prednisone in combination with azathioprine in the
treatment of autoimmune hepatitis. J Hepatol . 2008; 48:
S369-70.
- Kanzler S, Gerken G, Löhr H, et al. Duration of immunosuppressive
therapy in autoimmune hepatitis. J Hepatol . 2001; 34:354-5.
- Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of
inflammatory activity following corticosteroid treatment of
HBsAg-negative chronic active hepatitis. Hepatology . 1984; 4:
622-7.